Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.

Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor PJ, Brandle M, Smolen HJ, Gahn JC, Valentine WJ, Pollock RF, Breeze P, Brennan A, Pollard D, Ye W, Herman WH, Isaman DJ, Kuo S, Laiteerapong N, Tran-Duy A, Clarke PM.

Value Health. 2018 Jun;21(6):724-731. doi: 10.1016/j.jval.2018.02.002. Epub 2018 Apr 9.

2.

An Economic Evaluation of Stopping versus Continuing TNF-Inhibitor Treatment in Rheumatoid Arthritis Patients in Remission or Low Disease Activity: results from the POET randomized trial.

Tran-Duy A, Ghiti Moghadam M, Oude Voshaar MAH, Vonkeman HE, Boonen A, Clarke P, McColl G, Ten Klooster PM, Zijlstra TR, Lems WF, Riyazi N, Griep EN, Hazes JMW, Landewé R, Bernelot Moens HJ, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

Arthritis Rheumatol. 2018 May 9. doi: 10.1002/art.40546. [Epub ahead of print]

PMID:
29745059
3.

Longevity of outstanding sporting achievers: Mind versus muscle.

Tran-Duy A, Smerdon DC, Clarke PM.

PLoS One. 2018 May 3;13(5):e0196938. doi: 10.1371/journal.pone.0196938. eCollection 2018.

4.

Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.

Hua X, McDermott R, Lung T, Wenitong M, Tran-Duy A, Li M, Clarke P.

Eur J Prev Cardiol. 2017 Oct;24(15):1660-1669. doi: 10.1177/2047487317722913. Epub 2017 Jul 27.

5.

Reply.

Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CDA.

Clin Gastroenterol Hepatol. 2017 May;15(5):790. doi: 10.1016/j.cgh.2017.01.008. Epub 2017 Jan 20. No abstract available.

PMID:
28115211
6.

Construct Validity of Radiographs of the Feet to Assess Joint Damage in Patients with Gout.

Spaetgens B, van Durme C, Webers C, Tran-Duy A, Schoonbrood T, Boonen A.

J Rheumatol. 2017 Jan;44(1):91-94. doi: 10.3899/jrheum.160737. Epub 2016 Dec 1.

PMID:
27909088
7.

IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle.

Dagdeviren S, Jung DY, Friedline RH, Noh HL, Kim JH, Patel PR, Tsitsilianos N, Inashima K, Tran DA, Hu X, Loubato MM, Craige SM, Kwon JY, Lee KW, Kim JK.

FASEB J. 2017 Feb;31(2):701-710. doi: 10.1096/fj.201600832R. Epub 2016 Nov 3.

8.

Altered Interleukin-10 Signaling in Skeletal Muscle Regulates Obesity-Mediated Inflammation and Insulin Resistance.

Dagdeviren S, Jung DY, Lee E, Friedline RH, Noh HL, Kim JH, Patel PR, Tsitsilianos N, Tsitsilianos AV, Tran DA, Tsougranis GH, Kearns CC, Uong CP, Kwon JY, Muller W, Lee KW, Kim JK.

Mol Cell Biol. 2016 Nov 14;36(23):2956-2966. Print 2016 Dec 1.

9.

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.

Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD.

Clin Gastroenterol Hepatol. 2016 Dec;14(12):1706-1719.e5. doi: 10.1016/j.cgh.2016.05.018. Epub 2016 May 20. Review.

PMID:
27211501
10.

Implementation of Population Dynamics In Modelling Health And Budget Impact of An Intervention for A Chronic Disease With Multiple Disease Subtypes.

Tran-Duy A, Boonen A, Caro JJ, Severens JL.

Value Health. 2015 Nov;18(7):A700. doi: 10.1016/j.jval.2015.09.2618. Epub 2015 Oct 20. No abstract available.

11.

Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events: a Population-Based Cohort Study.

Tran-Duy A, Vanmolkot FH, Souverein PC, Hoes AW, de Boer A, Stehower CD, de Wit NJ, Joore MA, de Vries F.

Value Health. 2015 Nov;18(7):A378. doi: 10.1016/j.jval.2015.09.796. Epub 2015 Oct 20. No abstract available.

12.
13.

Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis.

Tran-Duy A, Nguyen TT, Thijs H, Baraliakos X, Heldmann F, Braun J, Boonen A.

Arthritis Care Res (Hoboken). 2015 Nov;67(11):1578-85. doi: 10.1002/acr.22655.

14.

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment.

Handels RL, Joore MA, Tran-Duy A, Wimo A, Wolfs CA, Verhey FR, Severens JL.

Alzheimers Dement. 2015 Aug;11(8):896-905. doi: 10.1016/j.jalz.2015.02.009. Epub 2015 Jun 9.

15.

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.

Tran-Duy A, Vanmolkot FH, Joore MA, Hoes AW, Stehouwer CD.

Int J Clin Pract. 2015 Oct;69(10):1088-111. doi: 10.1111/ijcp.12634. Epub 2015 Apr 6. Review.

PMID:
25846476
16.

Health and Utilities in Patients With Gout Under the Care of a Rheumatologist.

Spaetgens B, Tran-Duy A, Wijnands JM, van der Linden S, Boonen A.

Arthritis Care Res (Hoboken). 2015 Aug;67(8):1128-36. doi: 10.1002/acr.22551.

17.

Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.

Tran-Duy A, Boonen A, Kievit W, van Riel PL, van de Laar MA, Severens JL.

Pharmacoeconomics. 2014 Oct;32(10):1015-28. doi: 10.1007/s40273-014-0184-4.

PMID:
24972589
18.

How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.

van Haalen HG, Severens JL, Tran-Duy A, Boonen A.

Pharmacoeconomics. 2014 May;32(5):429-42. doi: 10.1007/s40273-014-0139-9. Review.

PMID:
24504853
19.

A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis.

Tran-Duy A, Boonen A, van de Laar MA, Franke AC, Severens JL.

Ann Rheum Dis. 2011 Dec;70(12):2111-8. doi: 10.1136/annrheumdis-2011-200333. Epub 2011 Aug 20.

PMID:
21857027

Supplemental Content

Loading ...
Support Center